A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult

Clinical trial NCT03784885 · COMPLETED

Trial details

NCT number: NCT03784885
Sponsor: Advagene Biopharma Co. Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Infection

Start date: 2017-09-01
Primary completion: 2018-01-07
Enrollment: 345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.